Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050596
Status:
COMPLETED
Last Update Posted:
2011-06-27
First Post:
2002-12-16
Brief Title:
Comparison Study of MDX-010 CTLA-4 Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-11
Start Date Type:
None
Primary Completion Date:
2004-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-11
Completion Date Type:
ACTUAL
First Submit Date:
2002-12-16
First Submit QC Date:
December 16 2002
Study First Post Date:
2002-12-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-06-23
Last Update Post Date:
2011-06-27
Last Update Post Date Type:
ESTIMATED